Cargando…

The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial

BACKGROUND: Epidemic viral diseases have become more prevalent.. Among the various strategies to prevent such epidemics, vaccination is the most cost-effective. However, populations that are immunized are typically already exposed to multiple previous vaccinations or natural infections. Studies from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Low, Jenny G, Wijaya, Limin, Li, Greg KY, Lim, Eleanor YL, Shum, Aland KL, Cheung, Yin-Bun, Ooi, Eng-Eong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404017/ https://www.ncbi.nlm.nih.gov/pubmed/25872531 http://dx.doi.org/10.1186/s13063-015-0651-z

Ejemplares similares

Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
por: Chan, Kuan Rong, et al.
Publicado: (2016)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Epidemiology, Outcomes and Prognosis of Central Nervous System Infections in Singapore. Preliminary results from The Singapore Neurologic Infections Programme (SNIP)
por: Chan, Fu Zi Yvonne, et al.
Publicado: (2017)

A protocol to assess cellular bioenergetics in flavivirus-infected cells
por: Low, John Z.H., et al.
Publicado: (2022)

Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells
por: Saron, Wilfried A. A., et al.
Publicado: (2018)

Current Status of Dengue Therapeutics Research and Development
por: Low, Jenny G. H., et al.
Publicado: (2017)

The re-emergence of dengue in China
por: Ooi, Eng Eong
Publicado: (2015)

A tribute to the late Emeritus Professor Chan Soh Ha
por: Ooi, Eng Eong
Publicado: (2021)

Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination
por: Ooi, Eng Eong, et al.
Publicado: (2022)

Disentangling etiologies of CNS infections in Singapore using multiple correspondence analysis and random forest
por: Zellweger, Raphaël M., et al.
Publicado: (2020)

Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
por: van Schie, Karin A, et al.
Publicado: (2015)

Evolution of Subgenomic RNA Shapes Dengue Virus Adaptation and Epidemiological Fitness
por: Finol, Esteban, et al.
Publicado: (2019)

Minding the “T”s beyond the “B”s: Shaping vaccines for future pandemics
por: Kalimuddin, Shirin, et al.
Publicado: (2023)

1376. A Retrospective Analysis of Intravenous Fluid Therapy Practice at Hospital Admission for Adults with Dengue
por: Chia, Yvonne M F, et al.
Publicado: (2023)

Oxygen: viral friend or foe?
por: Gan, Esther Shuyi, et al.
Publicado: (2020)

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine
por: Tschismarov, Roland, et al.
Publicado: (2021)

Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses
por: Tan, Cedric C.S., et al.
Publicado: (2021)

Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases
por: Chan, Kuan Rong, et al.
Publicado: (2015)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness
por: Kalimuddin, Shirin, et al.
Publicado: (2022)

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
por: Hanson, Brendon J, et al.
Publicado: (2006)

Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
por: Kalimuddin, Shirin, et al.
Publicado: (2021)

The Early Clinical Features of Dengue in Adults: Challenges for Early Clinical Diagnosis
por: Low, Jenny G. H., et al.
Publicado: (2011)

Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
por: Izmirly, Abdullah M., et al.
Publicado: (2020)

Dengue Prevention and 35 Years of Vector Control in Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2006)

Viral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion
por: Ong, Eugenia Z., et al.
Publicado: (2016)

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
por: Lau, Yuk-Fai, et al.
Publicado: (2009)

2505. A Novel Mobile Phone Application for Remote Research Data Collection is Effective in Monitoring Chronic Sequelae After Acute Viral Infections
por: Teh, Yii Ean, et al.
Publicado: (2018)

An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial
por: Kalimuddin, Shirin, et al.
Publicado: (2023)

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
por: Lim, Angeline PC, et al.
Publicado: (2008)

bla(OXA-181)–positive Klebsiella pneumoniae, Singapore
por: Koh, Tse H., et al.
Publicado: (2012)

Target product profile for a dengue pre-vaccination screening test
por: Fongwen, Noah, et al.
Publicado: (2021)

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
por: Lim, Angeline PC, et al.
Publicado: (2008)

Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus
por: Lim, Mei Qiu, et al.
Publicado: (2018)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
por: Henze, Larissa, et al.
Publicado: (2023)

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
por: Peluso, Michael J., et al.
Publicado: (2022)

Etiology of febrile respiratory infections in the general adult population in Singapore, 2007–2013
por: Chen, Yihui, et al.
Publicado: (2021)

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
por: Budigi, Yadunanda, et al.
Publicado: (2018)

Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution
por: Ong, Eugenia Z, et al.
Publicado: (2021)

Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention
por: Hall, Mark W, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pfdm4f5suktvhdmj62olf6gj0o